rigosertib sodium

Term ID

CHEBI:145421

Synonyms

(E)-ON 01910.Na
Estybon
novonex
ON 01910 sodium
ON 01910 sodium salt
ON 01910.Na
ON-01910 sodium
ON-01910 sodium salt
ON-01910.Na
rigosertib sodium salt
sodium [2-methoxy-5-({[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)anilino]acetate

Definition

The sodium salt of rigosertib. It is an anti-cancer agent which has been granted Orphan Drug Designation by the FDA for use in patients with myelodysplastic syndromes (MDS).

References

cas:592542-60-4
drugbank:DBSALT002144
kegg.drug:D10155
pubmed:15766665
pubmed:17588831
pubmed:18955447
pubmed:19029951
pubmed:19466411
pubmed:21646468
pubmed:21812421
pubmed:21924492
pubmed:22351695
pubmed:22524974
pubmed:22678771
pubmed:23386308
pubmed:23486532
pubmed:23738723
pubmed:23841031
pubmed:24493827
pubmed:24748653
pubmed:25316768
pubmed:27150054
pubmed:27764820
pubmed:28985505
pubmed:29423069

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from rigosertib sodium

Phenotype where environments contain rigosertib sodium

Phenotype modified by environments containing rigosertib sodium

Phenotype affecting rigosertib sodium

Human Disease Model